5/21/2024

Insulin Isophane (NPH) and Insulin Regular, Human

Products Affected - Description

- Novolin 70/30 subcutaneous suspension for injection, Novo Nordisk, 70 units/1 mL - 30 units/1 mL, 10 mL vial, NDC 00169-1837-11

Reason for the Shortage

- Novo Nordisk did not provide a reason for the shortage.
- Lilly has Humulin 70/30 in 3 mL KwikPens and 10 mL vials available. However, wholesalers may be allocating product.

Available Products

- Humulin 70/30 subcutaneous suspension for injection, Lilly USA, LLC, 70 units/1 mL - 30 units/1 mL, 10 mL vial, NDC 00002-8715-01
- Humulin 70/30 KwikPen subcutaneous suspension for injection, Lilly USA, LLC, 70 units/1 mL - 30 units/1 mL, 3 mL pen injector, 5 count, NDC 00002-8803-59
- Novolin 70/30 Flexpen subcutaneous suspension for injection, Novo Nordisk, 70 units/1 mL - 30 units/1 mL, 3 mL pen injector, 5 count, NDC 00169-3007-15

Estimated Resupply Dates

- Novo Nordisk has Novolin 70/30 in 10 mL vials on back order and the company estimates a release date in July 2024.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.